Transgenomic Names New CFO in Management Reorganization | GenomeWeb

NEW YORK, April 16 – Transgenomic said Monday it had appointed Gregory Duman as chief financial officer, replacing William Rasmussen, who will stay on as a strategic planner for the company.

Previously, Duman, who has been a member of Transgenomic’s board since March of last year, was the CFO of Artios, a company that provides transaction processing services. He also served as CFO and head of software product development at Transaction Systems Architects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.